(Q42205637)

18 October 2017

title

X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma (English)

1 reference

18 October 2017

1 reference

Ying Xie

1

1 reference

18 October 2017

Shufeng Liu

2

1 reference

18 October 2017

Yue Zhao

3

1 reference

18 October 2017

Zhanjun Guo

4

1 reference

18 October 2017

Jinsheng Xu

5

1 reference

18 October 2017

publication date

19 July 2014

1 reference

18 October 2017

1 reference

18 October 2017

volume

35

1 reference

18 October 2017

issue

10

1 reference

18 October 2017

page(s)

10325-10331

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2331-0

18 October 2017

exact match

0 references

cites work

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Epidemiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus genotypes: comparison of genotyping methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Viral hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Clinical relevance of hepatitis B viral mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus X protein targets the Bcl-2 protein CED-9 to induce intracellular Ca2+ increase and cell death in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Identification of functionally important amino acid residues in the mitochondria targeting sequence of hepatitis B virus X protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2331-0

Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia

21 January 2018

1 reference

12 December 2020

Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential

1 reference

12 December 2020

Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome

1 reference

12 December 2020

The hepatitis B virus posttranscriptional regulatory element is composed of two subelements

1 reference

12 December 2020

Management of hepatitis B in China

1 reference

12 December 2020

Predictive factors for postoperative recurrence of hepatocellular carcinoma.

1 reference

12 December 2020

10.1007/S13277-014-2331-0

Identifiers

DOI

1 reference

Dimensions Publication ID

18 October 2017

1006444848

0 references

1 reference